APA |
Yersal, O., Cengic, A., Cokpinar, S., Cetin, N. K., et al. (2018). Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?. Medical Science and Discovery, 5(10), 344-349. https://doi.org/10.17546/msd.470198 |
|
AMA |
Yersal O, Cengic A, Cokpinar S, Cetin NK, Meydan N, Barutca S, Sen S. Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?. Med Sci Discov. October 2018;5(10):344-349. doi:10.17546/msd.470198 |
|
Chicago |
Yersal, Ozlem, Arzu Cengic, Salih Cokpinar, Nesibe Kahraman Cetin, Nezih Meydan, Sabri Barutca, and Serdar Sen. “Does 18F FDG PET/CT Paramaters Predict Histopathologic Response to the Neoadjuvant Therapy in Patients With Non-Small Cell Lung Cancer?”. Medical Science and Discovery 5, no. 10 (October 2018): 344-49. https://doi.org/10.17546/msd.470198. |
|
EndNote |
Yersal O, Cengic A, Cokpinar S, Cetin NK, Meydan N, Barutca S, Sen S (October 1, 2018) Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?. Medical Science and Discovery 5 10 344–349. |
|
IEEE |
O. Yersal, A. Cengic, S. Cokpinar, N. K. Cetin, N. Meydan, S. Barutca, and S. Sen, “Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?”, Med Sci Discov, vol. 5, no. 10, pp. 344–349, 2018, doi: 10.17546/msd.470198. |
|
ISNAD |
Yersal, Ozlem et al. “Does 18F FDG PET/CT Paramaters Predict Histopathologic Response to the Neoadjuvant Therapy in Patients With Non-Small Cell Lung Cancer?”. Medical Science and Discovery 5/10 (October 2018), 344-349. https://doi.org/10.17546/msd.470198. |
|
JAMA |
Yersal O, Cengic A, Cokpinar S, Cetin NK, Meydan N, Barutca S, Sen S. Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?. Med Sci Discov. 2018;5:344–349. |
|
MLA |
Yersal, Ozlem et al. “Does 18F FDG PET/CT Paramaters Predict Histopathologic Response to the Neoadjuvant Therapy in Patients With Non-Small Cell Lung Cancer?”. Medical Science and Discovery, vol. 5, no. 10, 2018, pp. 344-9, doi:10.17546/msd.470198. |
|
Vancouver |
Yersal O, Cengic A, Cokpinar S, Cetin NK, Meydan N, Barutca S, Sen S. Does 18F FDG PET/CT paramaters predict histopathologic response to the neoadjuvant therapy in patients with non-small cell lung cancer?. Med Sci Discov. 2018;5(10):344-9. |
|